These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33475056)

  • 1. A Comprehensive Review on Pellets as a Dosage Form in Pharmaceuticals.
    Handattu MS; Thirumaleshwar S; Prakash GM; Somareddy HK; Veerabhadrappa GH
    Curr Drug Targets; 2021; 22(10):1183-1195. PubMed ID: 33475056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets.
    Pavloková S; Muselík J; Sabadková D; Bernatová S; Samek O; Neumann D; Franc A
    Eur J Pharm Sci; 2019 Apr; 132():86-95. PubMed ID: 30825510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronopharmacokinetic Evaluation of Budesonide Multiparticulate Systems.
    Battu S; Yalavarthi PR; Gopireddy VSR; Vattikuti UMR; Devi J; Vadlamudi HC
    Recent Pat Drug Deliv Formul; 2017; 11(3):221-229. PubMed ID: 29237390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS).
    Abdul S; Chandewar AV; Jaiswal SB
    J Control Release; 2010 Oct; 147(1):2-16. PubMed ID: 20493217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical modelling of the drug release from an ensemble of coated pellets.
    Caccavo D; Lamberti G; Cafaro MM; Barba AA; Kazlauske J; Larsson A
    Br J Pharmacol; 2017 Jun; 174(12):1797-1809. PubMed ID: 28276575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
    Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
    Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Pellet Cushioning Agents by Various Imaging Techniques and Dissolution Studies.
    Sántha K; Kállai-Szabó N; Fülöp V; Jakab G; Gordon P; Kállai-Szabó B; Balogh E; Antal I
    AAPS PharmSciTech; 2020 Dec; 22(1):14. PubMed ID: 33377174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study on the influence of solvent composition on the architecture of drug-layered pellets.
    McConnell EL; Macfarlane CB; Basit AW
    Int J Pharm; 2009 Oct; 380(1-2):67-71. PubMed ID: 19589378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushion-coated pellets for tableting without external excipients.
    Moutaharrik S; Palugan L; Cerea M; Filippin I; Maroni A; Gazzaniga A; Foppoli A
    Int J Pharm; 2024 Mar; 653():123874. PubMed ID: 38316318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization.
    Hamdani J; Moës AJ; Amighi K
    Int J Pharm; 2006 Sep; 322(1-2):96-103. PubMed ID: 16824707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
    Pai R; Kohli K; Jain G; Srivastava B
    Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles and multi-unit systems for advanced drug delivery.
    Kállai-Szabó N; Farkas D; Lengyel M; Basa B; Fleck C; Antal I
    Eur J Pharm Sci; 2024 Mar; 194():106704. PubMed ID: 38228279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquisolid Pellets and Liqui-Pellets Are Not Different.
    Pezzini BR; Beringhs AO; Ferraz HG; Silva MAS; Stulzer HK; Sonaglio D
    AAPS PharmSciTech; 2020 Jan; 21(2):72. PubMed ID: 31953566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelletization processes for pharmaceutical applications: a patent review.
    Politis SN; Rekkas DM
    Recent Pat Drug Deliv Formul; 2011 Jan; 5(1):61-78. PubMed ID: 21143125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro behavior of dronedarone hydrochloride loaded pellets using vacuum impregnation technique.
    Gretić M; Štanfel M; Barbarić J; Rimac N; Matijašić G
    Eur J Pharm Biopharm; 2021 May; 162():70-81. PubMed ID: 33727144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
    Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
    Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twin-screw extrusion of sustained-release oral dosage forms and medical implants.
    Feng X; Zhang F
    Drug Deliv Transl Res; 2018 Dec; 8(6):1694-1713. PubMed ID: 29235074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.